Want to join the conversation?
IT management software maker $CA reported a decline in 1Q17 earnings due to higher costs and expenses despite a 2% rise in revenues. Net income fell to $198MM or $0.47 per share from $212MM or $0.48 per share last year. Revenue grew to $999MM from $977MM. Non-GAAP EPS waS $0.64, flat with last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?